logo
DBS Sticks to Their Buy Rating for JD Logistics, Inc. (2618)

DBS Sticks to Their Buy Rating for JD Logistics, Inc. (2618)

In a report released today, Zoe Zhang from DBS maintained a Buy rating on JD Logistics, Inc., with a price target of HK$18.00. The company's shares closed yesterday at HK$13.96.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Zhang covers the Industrials sector, focusing on stocks such as JD Logistics, Inc., ZTO Express, and ZTO Express (Cayman), Inc. Class A. According to TipRanks, Zhang has an average return of -1.3% and a 25.00% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for JD Logistics, Inc. with a HK$15.33 average price target.
The company has a one-year high of HK$16.84 and a one-year low of HK$7.68. Currently, JD Logistics, Inc. has an average volume of 11.02M.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cognigy is a Leader in the 2025 Gartner® Magic Quadrant™ for Enterprise Conversational AI Platforms
Cognigy is a Leader in the 2025 Gartner® Magic Quadrant™ for Enterprise Conversational AI Platforms

Business Wire

time17 minutes ago

  • Business Wire

Cognigy is a Leader in the 2025 Gartner® Magic Quadrant™ for Enterprise Conversational AI Platforms

DALLAS & DÜSSELDORF, Germany & LONDON--(BUSINESS WIRE)-- Cognigy, a global leader in AI-powered customer service solutions, today announced that the company has been named a Leader in the Gartner® Magic Quadrant™ for Enterprise Conversational AI Platforms for its platform Access a complimentary copy of the report. 'We believe being positioned in the Leaders Quadrant in the Gartner Magic Quadrant for the third time isn't just an acknowledgement—it's validation of the bold path we've taken,' said Philipp Heltewig, CEO and Co-founder of Cognigy. 'We set out to redefine what's possible in customer service with Agentic AI, and is delivering on that promise every day. Enterprises worldwide are using our platform not only to automate but to elevate experiences—creating customer service that is smarter, more human, and built for what's next.' The platform powers next-generation customer service by creating AI Agents that combine automation, Generative AI, and real-time support for human agents. It delivers a full suite of capabilities, including intelligent self-service across voice and digital channels, agent assist with real-time guidance, and advanced orchestration that connects seamlessly with existing contact center systems. With built-in multilingual support, deep integrations, and enterprise-grade security, enables organizations to provide 24/7, hyper-personalized experiences at scale while boosting operational efficiency and employee satisfaction. A Gartner Magic Quadrant is a culmination of research in a specific market, giving a wide-angle view of the relative positions of the market's competitors. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries, and Niche Players. The research enables businesses to get the most from market analysis in alignment with their unique business and technology needs. To learn more, access a complimentary copy of the report at Gartner disclaimer Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Source: Gartner, Gartner, 'Magic Quadrant for Enterprise Conversational AI Platforms,' by analysts Gabriele Rigon, Justin Tung, Bern Elliot, Arup Roy, Adrian Lee, Uma Challa, 13 August 2025. About Cognigy Cognigy is transforming the customer service industry with the most advanced AI Agent platform for enterprise contact centers. Its award-winning solution, empowers enterprises to deliver instant, hyper-personalized, multilingual service on any channel. By integrating Generative and Conversational AI to create Agentic AI, Cognigy delivers AI Agents that redefine customer experiences, drive satisfaction, and support contact center employees in real-time. Over 1000 brands worldwide trust Cognigy and its vast partner network to create AI customer service agents for their contact center. Cognigy's impressive worldwide customer portfolio includes Bosch, Nestlé, DHL, Frontier Airlines, Lufthansa Group, Mercedes-Benz and Toyota. For more information and to book a demo visit: Follow the company on X (formerly Twitter) @Cognigy and on LinkedIn at

Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer
Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

Associated Press

time41 minutes ago

  • Associated Press

Centerline Biomedical Appoints Jim Dillon President and Chief Executive Officer

CLEVELAND--(BUSINESS WIRE)--Aug 18, 2025-- Centerline Biomedical, Inc. ('Centerline'), an innovative leader in cardiovascular navigation and visualization systems, announced the appointment of Jim Dillon as President and Chief Executive Officer (CEO) and a member of its board of directors. He will assume his responsibilities on August 18, 2025. Mr. Dillon succeeds Gulam Khan, who has served as CEO since October 2022. Mr. Khan led Centerline Biomedical through a period of portfolio development. During his tenure, Centerline Biomedical developed, received 510(k) clearance, and commercialized its second-generation devices and appreciable software advances. We appreciate Gulam's significant contributions. 'It is an honor to join Centerline at such a pivotal stage. The IOPS platform is poised for scaled growth and I am grateful to have the opportunity to lead the company as it continues to innovate such remarkable technology for patients and care givers,' said Mr. Dillon. 'With decades of med tech industry leadership, Jim brings deep cardiovascular sector experience leading portfolio innovation, operational alignment, and strategic financing for med tech companies,' said Todd Schwarzinger, Centerline's Chairman. 'Jim has a strong track record of driving commercial growth through category creation and market penetration and we are excited to have him leading Centerline.' Mr. Dillon has previously served as President and CEO for cardiovascular innovation companies; BiVACOR, BioVentrix, Reprieve Cardiovascular and Renal Guard Solutions. To learn more about the IOPS platform, visit About Centerline Biomedical Founded in 2015, Centerline Biomedical, Inc. is headquartered in Cleveland, Ohio. The company's commercially available platform, IOPS® (Intra-Operative Positioning System), enables improved visualization and device navigation, while protecting patient and healthcare provider exposure from the harmful effects of fluoroscopic X-ray radiation during standard interventions. The company is a Cleveland Clinic Innovations spin-off investing in commercialization and development of technology to improve image guidance and reduce the need for fluoroscopic x-ray during transcatheter procedures. IOPS is indicated for use in the peripheral, aortic and aortic side branch vasculature. The IOPS platform consists of a mobile cart powered by proprietary visualization software and intelligent, sensorized IOPS catheters and guidewires. Visit for more information. View source version on CONTACT: For inquiries, please contact: Patty Burns, SVP Marketing Centerline Biomedical, Inc. Email:[email protected] KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: CARDIOLOGY SOFTWARE RADIOLOGY HEALTH MEDICAL DEVICES HOSPITALS HEALTH TECHNOLOGY TECHNOLOGY SOURCE: Centerline Biomedical, Inc. Copyright Business Wire 2025. PUB: 08/18/2025 11:00 AM/DISC: 08/18/2025 11:00 AM

Cinemark to Dual List Common Stock on NYSE Texas
Cinemark to Dual List Common Stock on NYSE Texas

Business Wire

timean hour ago

  • Business Wire

Cinemark to Dual List Common Stock on NYSE Texas

PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. ('Cinemark') (NYSE: CNK), one of the largest and most influential theatrical exhibition companies in the world, today announced the dual listing of its common stock on NYSE Texas, the newly launched, fully electronic equities exchange headquartered in Dallas, Texas. Cinemark has been listed on the New York Stock Exchange (NYSE) since 2007, and this dual listing further strengthens its longstanding relationship with the exchange. Cinemark will retain its primary listing on the NYSE and will trade under the ticker symbol 'CNK' on both exchanges. 'We have a deep-rooted presence in Texas - with more than 25% of our domestic theaters in the Lone Star State, our company service center in Plano, and thousands of team members serving millions of guests throughout the state each year,' said Sean Gamble, Cinemark President and CEO. 'We are thrilled to further strengthen our connection to Texas through our dual listing on NYSE Texas while supporting the state's expanding financial ecosystem and providing opportunities for investors focused on localized, regional market opportunities.' 'As a leading movie theater company based in Texas, Cinemark is a natural addition to our community of NYSE Texas Founding Members,' said Bryan Daniel, President, NYSE Texas. About Cinemark Holdings, Inc.: Headquartered in Plano, TX, Cinemark (NYSE: CNK) is one of the largest and most influential movie theater companies in the world. Cinemark's circuit, comprised of various brands that also include Century, Tinseltown and Rave, as of June 30, 2025 operated 497 theaters with 5,647 screens in 42 states domestically and 13 countries throughout South and Central America. Cinemark consistently provides an extraordinary guest experience from the initial ticket purchase to the closing credits, including Movie Club, the first U.S. exhibitor-launched subscription program; the highest Luxury Lounger recliner seat penetration among the major players; XD - the No. 1 exhibitor-brand premium large format; and expansive food and beverage options to further enhance the moviegoing experience. For more information go to

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store